Narrow search
Showing 1 - 10 of 636
Cover Image
The Effect of Intellectual Property Rights on Domestic Innovation in the Pharmaceutical Sector
Gamba, Simona - 2016
This paper analyses the causal impact of Intellectual Property Rights (IPR) on pharmaceutical innovation in a panel of …. Domestic innovation is measured as citation-weighted domestic patents filed at the European Patent Office (EPO): to account for … to patent at the EPO. Results show that, in the short-run, IPR stimulate innovation. The effect for developing countries …
Persistent link: https://www.econbiz.de/10012984725
Cover Image
Pharmaceutical Patents : Incentives for R&D or Marketing?
Brekke, Kurt Richard; Straume, Odd Rune - 2021
We analyse how a patent-holding pharmaceutical firm may strategically use advertising of existing drugs to affect R&D investments in new (differentiated) drugs, and thereby affect the probability distribution of future market structures in the industry. Within a fairly general model framework,...
Persistent link: https://www.econbiz.de/10013316463
Cover Image
Patient Mobility, Health Care Quality and Welfare
Brekke, Kurt Richard; Levaggi, Rosella; Siciliani, Luigi; … - 2021
Patient mobility is a key issue in the EU who recently passed a new law on patients’ right to EU-wide provider choice. In this paper we use a Hotelling model with two regions that differ in technology to study the impact of patient mobility on health care quality, health care financing and...
Persistent link: https://www.econbiz.de/10013315635
Cover Image
Private versus Social Incentives for Pharmaceutical Innovation
Gonzalez, Paula - 2016
We provide a theoretical framework to contribute to the current debate regarding the tendency of pharmaceutical companies to direct their R&D toward marketing products that are “follow-on” drugs of already existing drugs, rather than toward the development of breakthrough drugs. We construct...
Persistent link: https://www.econbiz.de/10013000227
Cover Image
Does Pharmaceutical Price Regulation Affect the Adoption of Generic Competition? Evidence from the OECD, 1999-2008
Varol, Nebibe - 2014
efficiency and stimulates pharmaceutical innovation. There is no prior study that has empirically analysed the relative delays in …
Persistent link: https://www.econbiz.de/10013068052
Cover Image
Competition, Imitation, and R&D Productivity in a Growth Model with Sector-Specific Patent Protection
Mosel, Malte - 2021
intricate reverse engineering are. Unlike similar step-by-step innovation models of economic growth, the model assumes Cournot …
Persistent link: https://www.econbiz.de/10013316194
Cover Image
A Simple Model of Health Insurance Competition
Kemnitz, Alexander - 2010
This paper investigates competition between health insurance companies under different financing regulations. We consider two alternatives advanced in recent German health care reform discussions: competition by contribution rates (health contributions) and by fees (health premia). We find that...
Persistent link: https://www.econbiz.de/10013136650
Cover Image
Hospital Competition with Soft Budgets
Brekke, Kurt Richard - 2013
We study the incentives for hospitals to provide quality and expend cost-reducing effort when their budgets are soft, i.e., the payer may cover deficits or confiscate surpluses. The basic set up is a Hotelling model with two hospitals that differ in location and face demand uncertainty, where...
Persistent link: https://www.econbiz.de/10013087727
Cover Image
Margins and Market Shares : Pharmacy Incentives for Generic Substitution
Brekke, Kurt Richard - 2013
We study the impact of product margins on pharmacies' incentive to promote generics instead of brand-names. First, we construct a theoretical model where pharmacies can persuade patients with a brand-name prescription to purchase a generic version instead. We show that pharmacies' substitution...
Persistent link: https://www.econbiz.de/10013088216
Cover Image
Hospital Competition and Quality with Regulated Prices
Brekke, Kurt Richard - 2010
We analyse the effect of competition on quality in hospital markets with regulated prices, considering both the effect of (i) introducing competition (monopoly versus competition) and (ii) increasing competition through lower transportation costs (increased substitutability) or a higher number...
Persistent link: https://www.econbiz.de/10013152862